paclitaxel has been researched along with selinexor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carter, BW; Colen, R; Fu, S; Gong, J; Hong, DS; Janku, F; Karp, DD; McQuinn, L; Meric-Bernstam, F; Milton, DR; Naing, A; Piha-Paul, SA; Shah, J; Stephen, BA; Sulovic, S; Thein, KZ; Tsimberidou, A; Yap, TA | 1 |
| Akhmedzhanov, F; Brink, AL; Carter, B; Coleman, RL; Fu, S; Gershenson, D; Gong, J; Hong, DS; Jazaeri, A; Leung, CH; Lin, H; McQuinn, L; Meric-Bernstam, F; Naing, A; Pant, S; Piha-Paul, S; Shah, J; Sood, AK; Tsimberidou, A; Westin, SN; Yilmaz, B | 1 |
2 trial(s) available for paclitaxel and selinexor
| Article | Year |
|---|---|
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Humans; Hydrazines; Lung Neoplasms; Nausea; Neoplasms; Ovarian Neoplasms; Paclitaxel; Thrombocytopenia; Triazoles; Vomiting | 2022 |
Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Hydrazines; Male; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Ovarian Neoplasms; Paclitaxel | 2023 |